> CRO Agility Clinical has reached Phase III with sponsor Imprimis Pharmaceuticals ($IMMY), planning to test the safety and efficacy of Impracor, a treatment for osteoarthritic knee pain. News
> Thanks to ample resources and an uncomplicated regulatory environment, sponsors and CROs are flocking to Russia for clinical trials. Report
> Accenture is pouring millions of dollars into its R&D optimization technology, looking to compete with CROs. Article